School of Medicine
Showing 1-100 of 177 Results
-
Ramesh Nair
Director of Bioinformatics, SCGPM, Genetics
Current Role at StanfordDirector, Bioinformatics
Stanford Center for Genomics and Personalized Medicine (SCGPM)
Bioinformatics-as-a-Service (BaaS)
Genetics Bioinformatics Service Center (GBSC)
Diabetes Genomics Analysis Core (DGAC)
Stanford University School of Medicine -
Michitaka Nakano
Basic Life Research Scientist, Medicine - Med/Hematology
BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.
-
Yusuke Nakauchi, MD, PhD
Basic Life Research Scientist, Stem Cell Bio Regenerative Med Institute
BioMy research projects aim to investigate the biology of human leukemia. I believe my research will contribute to clarify the disease pathogenesis of leukemia and help identify the critical cells to target to both prevent the development of de novo leukemia and halt relapse.
-
Anjali Nambiar
Social Science Research Professional 1, Stanford-Surgery Policy Improvement Research and Education Center
BioAnjali Nambiar, B.S., is a Social Science Research Professional at the Surgery Policy Improvement Research and Education (S-SPIRE) Center. Anjali completed her degree in Biological Sciences. She has coordinated a variety of clinical research projects and worked with several public health nonprofits to implement new programs at community-based clinics and organizations.
-
Arutselvan Natarajan
Senior Research Scientist - Basic Life, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Scientist
-
Michael Nedelman
Adjunct Lecturer, Medicine - Primary Care and Population Health
BioDr. Michael Nedelman leads the Stanford Health Equity Media Fellowship. He previously covered health and medicine as a journalist for CNN, earning an Emmy nomination for the network's acclaimed reporting on the Covid-19 pandemic. As producer for the inimitable Dr. Sanjay Gupta, he was part of a team known for excellent reporting and storytelling — also winning a Cronkite Award for tackling misinformation during the pandemic. Before CNN, he was a digital producer for the ABC News Medical Unit, worked on public health campaigns at the World Health Organization in New Delhi, and trained at the Stanford Journalism Program as part of the university's Global Health Media Fellowship. He received his MD from Stanford and did his undergraduate work in film at Yale.
-
Margaret Jane Neff
Clinical Associate Professor (Affiliated), Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
Medical Director--Vapahcs Medical Surgical Icu, Medicine - Med/Pulmonary, Allergy & Critical Care MedicineBioMy training is in Pulmonary & Critical Care Medicine, and I've been blessed to be part of the care of many patients and their families. My clinical research interests have been in the field of critical care medicine and ARDS, a type of acute respiratory failure seen commonly in patients with severe injuries or illnesses. I also have a particular interest in evaluating and improving processes for care. Issues like standardizing processes to improve reliability, improving safety of handoffs, and exploring ways to teach "roundsmanship" (the process of discussing patients' care with a group of providers) are current interests of mine.
The future of medical care depends on training the next generation of providers, and I'm thankful to be part of training this next generation. Teaching at the bedside or in formal classroom settings gives me great joy and satisfaction. I'm delighted to work with a great, multidisciplinary team of physicians, nurse practitioners, nurses, respiratory therapists, and pharmacists. I add to that team our patients and families, for it truly takes a team to provide care that is both excellent and compassionate. -
Hesam N. Motlagh
Adjunct Professor, Structural Biology
BioHesam is passionate about translating basic science discoveries into products that have a significant impact on society. He is Chief of Staff at Khosla Ventures where he works with Vinod Khosla on strategic projects for the firm and advises portfolio companies on fundraising, product, business development, marketing, and general strategy.
Currently, Hesam is an Adjunct Professor in the Department of Structural Biology at Stanford Medicine and a Fellow in The Johns Hopkins Institute for Applied Economics, Global Health, and the Study of Business Enterprise where he is editor of the Studies in Applied Finance. Previously, he worked on financial and corporate strategy at Seer Biosciences and was a Pear Fellow at Pear VC. Before Seer, he was a quant at an investment management firm after being a molecular and computational biophysicist for almost a decade.
Hesam has many peer-reviewed publications including a review article that was highlighted on the cover of Nature. He completed his MBA at Stanford Graduate School of Business, obtained his PhD from the Program in Molecular Biophysics at The Johns Hopkins University under the supervision of Vincent Hilser, and obtained his undergraduate degrees from Miami University in Oxford, Ohio. -
Gernot Neumayer
Senior Research Scientist, Stem Cell Bio Regenerative Med Institute
Current Role at StanfordSenior Scientist
-
Henry Hoang Nguyen
MD Student with Scholarly Concentration in Bioengineering / Quality Improvement, expected graduation Spring 2027
Other Tech - Graduate, Technology & Digital SolutionsBioHenry Nguyen was born and raised in Abbeville, Louisiana, and is a proud graduate of Xavier University of Louisiana. Before becoming a Stanford medical student in 2022, Henry co-founded organizations dedicated to increasing inclusivity in the fields of competitive athletics, the performing arts, and media production. Stanford’s distinct environment has allowed him to continue nurturing these organizations during medical school, and he has also picked up new projects contributing to cutting-edge innovation in the fields of biotechnology, medical education, and video game design.
Henry has taken classes at Stanford’s law school, business school, and engineering school to augment his MD education. He then applied these skills to assist multiple companies in successfully acquiring venture capital funding, and he continues to serve as a trusted advisor to major Artificial Intelligence firms, such as Synaptiq Learning, Anthropic, and Snorkel AI. Henry is the youngest person to ever be elected to the Stanford Medicine Alumni Board of Governors and has been awarded multiple Stanford-based grants to support his scholarly activity in neuroimaging. Lastly, he has actively supported the Stanford Medicine Radiology Department by reviving the Radiology Interest Group, leading pre-clinical radiology electives, and designing a completely new radiology clerkship.
Henry hopes to follow the example of his mentors by using the unique merits of radiology to combine his passions for clinical care, academic scholarship, and industrial innovation. Most importantly, he plans to dedicate his career to increasing access to state-of-the-art healthcare, so that the advancements of his classmates and colleagues can one day be available to the patients in his hometown.
